Home
Conditions
Autoimmune Diseases of the Nervous System

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,227 public trials 541 recruiting studies

Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Completed

Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

NCT01074346

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Samsung Medical Center Seoul, 50 Ilwon-dong, Gangnam-gu, South Korea

View Trial Details

Completed

Assessment of Patient Use of a New Device: RebiSmart

NCT01195870

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers

NCT01075737

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +7 more
Locations: 25 de Mayo 138, Capital, Pcia. de Santiago del Estero, Argentina

View Trial Details

Completed

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

NCT00213135

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Not specified

View Trial Details

Completed

An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device

NCT01601080

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Please contact the Merck KGaA Communication Center For Recruiting Locations, United Kingdom

View Trial Details

Completed

Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

NCT01195857

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF)

NCT01110993

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Medical University, Department of Neurology Lublin, Poland

View Trial Details

Completed

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

NCT01591551

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: South Shore Neurologic Associates Patchogue, New York, United States

Cornerstone Neurology High Point, North Carolina, United States

Providence Brain Institute Portland, Oregon, United States

View Trial Details

Completed

REbif FLEXible Dosing in Early Multiple Sclerosis (MS)

NCT00404352

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Research Site Mendoza, Argentina

Research Site Sydney, Australia

Research Site Graz, Austria

Research Site Innsbruck, Austria

View all 67 locations

View Trial Details

Completed

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

NCT00490906

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bone Diseases, +10 more
Locations: General Clinical Research Center Kansas City, Kansas, United States

University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Autoimmune Diseases of the Nervous System

Autoimmune Diseases of the Nervous System trial results

Related conditions